Activity ID
3732Expires
November 17, 2025Format Type
EnduringCME Credit
0.5Fee
$20CME Provider: American Medical Association
Description of CME Course
Large tumor profiling panels can test hundreds of genetic variants that may drive cancer growth, and suggest targeted therapeutics for the variants identified. This module provides an overview of their benefits and limitations, and examines which patients may be good candidates.
Disclaimers
1. This activity is hosted on the AMA Ed Hub.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Identify the types of clinical information that can be gained from large somatic cancer panels
2. Determine how large somatic cancer panel results could be applied to patient care
Keywords
Cancer Genetics, Genetics and Genomics, Oncology, Targeted and Immune Cancer Therapy
Competencies
Medical Knowledge, Patient Care & Procedural Skills
CME Credit Type
AMA PRA Category 1 Credit
